Table 1.
Clinical characteristic of ITP patients and controls.
| Population | Age (year) | Gender, female (%) | WBC (×109/L) | RBC (×1012/L) | HB (g/L) | PLT (×109/L) |
|---|---|---|---|---|---|---|
| Stage 1 | ||||||
| Cases (n = 200) | 40.36 ± 16.39 | 135 (67.5) | 8.72 ± 4.53 | 3.95 ± 0.79 | 114.33 ± 25.31 | 16.10 ± 27.22 |
| Controls (n = 200) | 40.78 ± 16.03 | 135 (67.5) | 6.57 ± 1.60 | 4.39 ± 0.36 | 131.18 ± 11.41 | 207.36 ± 50.34 |
| P | <0.001 | <0.001 | <0.001 | <0.001 | ||
| Stage 2 | ||||||
| Cases (n = 250) | 40.85 ± 12.21 | 168 (67.2) | 8.46 ± 4.72 | 3.68 ± 0.90 | 105.96 ± 26.46 | 24.57 ± 35.04 |
| Controls (n = 250) | 41.63 ± 12.99 | 168 (67.2) | 5.86 ± 1.68 | 4.27 ± 0.37 | 134.00 ± 11.31 | 201.96 ± 53.35 |
| P | <0.001 | <0.001 | <0.001 | <0.001 |
WBC, white blood cell; RBC, red blood cell; HB, hemoglobin; PLT, platelet count. The significance threshold is P value <0.05.